11-12 September 2018 //  Lancaster Royal Hotel, London


Mohamed Abou El-Enein

Prof Mohamed Abou El-Enein

Head of Clinical Development Platform, Translational Research Specialist, Berlin-Brandenburger Centre for Regenerative Therapies (BCRT); Charité Universitätsmedizin Berlin

Dr. Abou-El-Enein is a Junior Professor of clinical development of regenerative medicine and head of the clinical development platform at Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité University Hospital. The platform is responsible for transforming the research findings of the scientists into clinical applications. He serves as a Senior Teaching Assistant in clinical research at Harvard T.H. Chan School of Public Health and Instructor in Translational Medicine and Regulatory Science at the Berlin-Brandenburg School for Regenerative Therapies (BSRT). He received a master’s degree in Pharmaceutical Sciences and Biotechnologies from Strasbourg University, a Clinical Research Certificate from Harvard Medical School and a Doctoral Degree in Economics Research for Cellular Therapies, summa cum laude, from Charité University Hospital. Dr. Abou-El-Enein has more than 7 years of experience in the development and clinical translation of cell and gene therapies where he has succeeded to bring numerous advanced therapies into early phase clinical trials.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad